Proliferative cutaneous disease states or conditions are treated by administering a polyamine transport inhibitor
R-X-L-polyamine
wherein R is a straight or branched C10-50 saturated or unsaturated aliphatic, carboxyalkyl, carbalkoxyalkyl, or alkoxy; a C1-8 alicyclic; a single or multiring aryl substituted or unsubstituted aliphatic; and aliphatic-substituted or unsubstituted single or multiring aromatic; a single or multiring heterocyclic; a single or multiring heterocyclic aliphatic; an aryl sulfonyl;
X is —CO—, —SO
2
—, or —CH
2
—; and L is a covalent bond or a naturally occurring amino acid, lysine, ornithine, 2,4-diaminobutyric acid, or pharmaceutically acceptable salts thereof or prodrug thereof, and a polyamine biosynthesis inhibitor.
                            通过施用
多胺转运
抑制剂治疗增生性皮肤疾病状态或病症
R-X-L-
多胺
其中 R 是直链或支链 C10-50 饱和或不饱和脂肪族、羧基烷基、烷氧基烷基或烷氧基;C1-8脂环族;取代或未取代脂肪族的单系或多系芳基;以及脂肪族取代或未取代的单系或多系芳基;单系或多系杂环族;单系或多系杂环脂肪族;芳基磺酰基;
X 是-CO-、-SO
2
-或-CH
2
-L是共价键或天然
氨基酸、赖
氨酸、
鸟氨酸、
2,4-二氨基丁酸或其药学上可接受的盐或原药,以及
多胺生物合成
抑制剂。